Latest California Healthline Stories
States Pass Record Number Of Laws To Reel In Drug Prices
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
Estados promulgan leyes para frenar los precios de los medicamentos
En lo que va del año, 33 han promulgado un récord de 51 leyes para confrontar los precios, la accesibilidad y el acceso a los medicamentos.
Listen: India Gives Opioid Makers A Huge And Growing New Market
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Comparando las farmacias de tu vecindario con las de Alemania
No son como CVS, Rite Aid o Walgreens, las que tienes a la vuelta de la esquina. Die Apotheke, como se llama aquí a una farmacia, vende casi exclusivamente medicamentos.
Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.